bluebird bio CEO Nick Leschly's 2019 pay falls 45% to $13M
bluebird bio reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
bluebird bio reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, six executives at bluebird bio received on average a compensation package of $6.7M, a 40% decrease compared to previous year.
Average pay of disclosed executives at bluebird bio
Nick Leschly, Chief Executive Officer, received $13M in total, which decreased by 45% compared to 2018. 66% of Leschly's compensation, or $8.7M, was in option awards. Leschly also received $418K in non-equity incentive plan, $660K in salary, $3.4M in stock awards, as well as $11K in other compensation.
William D. Baird, III, Chief Financial Officer, received a compensation package of $9.2M. 66% of the compensation package, or $6.1M, was in option awards.
Jeffrey T. Walsh, Former Chief Strategy Officer, earned $5.3M in 2019, a 43% decrease compared to previous year.
David Davidson, Chief Medical Officer, received $5.2M in 2019, which decreases by 44% compared to 2018.
Philip D. Gregory, Chief Scientific Officer, earned $3.9M in 2019, a 55% decrease compared to previous year.
Jason F. Cole, Chief Operating and Legal Officer, received $3.6M in 2019, which decreases by 32% compared to 2018.
Related executives
Nick Leschly
bluebird bio
Chief Executive Officer
William Baird
bluebird bio
Chief Financial Officer
Jeffrey Walsh
bluebird bio
Former Chief Strategy Officer
David Davidson
bluebird bio
Chief Medical Officer
Philip Gregory
bluebird bio
Chief Scientific Officer
Jason Cole
bluebird bio
Chief Strategy & Financial Officer former
You may also like
Source: SEC filing on April 27, 2020.